ADVFN - Advanced Financial Network.
HOME» NASDAQ » T » TEVA Stock Price » TEVA Stock News

Teva Pharmaceutical Share News

 Teva Pharmaceutical Industries Limited (mm) Stock Price
TEVA Stock Price
 Teva Pharmaceutical Industries Limited (mm) Stock Chart
TEVA Stock Chart
 Teva Pharmaceutical Industries Limited (mm) Stock News
TEVA Stock News
 Teva Pharmaceutical Industries Limited (mm) Company Information
TEVA Company Information
 Teva Pharmaceutical Industries Limited (mm) Stock Trades
TEVA Stock Trades

Teva Receives FDA Approval For Generic Lexapro For Adults

DOW JONES NEWSWIRES Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) has received U.S. Food and Drug Administration approval to market the first generic version of Forest Laboratories Inc.'s (FRX) Lexapro for adults. The generic drug--escitalopram--is approved to treat depression and generalized anxiety disorder. The world's biggest manufacturer of generic drugs said Wednesday it has been granted a 180-day period of generic-drug exclusivity, which means the FDA can't approve another generic version of escitalopram tablets before the end of that period. Teva, which has diversified into brand-name and over-the-counter drugs, in February expected sales growth for its U.S. generics business to outpace market growth during 2012. Lexapro has been Forest Labs's main money maker. The company in January reported Lexapro sales of $593 million for its fiscal third quarter. Teva last month reported that its fourth-quarter profit declined 34%, as higher acquisition-related costs more than offset a revenue increase fueled by last year's purchase of Cephalon Inc. -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stock News for Teva Pharmaceutical (TEVA)
DateTimeHeadline
03/30/201508:14:08Teva to Acquire Auspex in $3.2 Billion Deal
03/23/201509:59:36Teva Migraine Therapy Shows Positive Results in Phase IIb Study
03/02/201509:50:38Correction to Story About Teva Selling Pennsylvania Facility
03/02/201509:18:27Teva Sells Pennsylvania Facility to G&W Laboratories
02/17/201508:33:57Teva to Distribute Eagle Pharmaceutical's Cancer Drug in U.S.
01/26/201508:10:04FDA Rejects Antares' Application for Generic Migraine Drug
08/19/201401:55:00Gamida Cell Announces Investment and Option Agreement with Major...

Teva Pharmaceutical and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad